Nathan Treybeck
Stock Analyst at Wells Fargo
(2.79)
# 1,932
Out of 4,761 analysts
16
Total ratings
60%
Success rate
21.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LMAT LeMaitre Vascular | Initiates: Equal-Weight | $95 | $99.54 | -4.56% | 1 | Feb 13, 2025 | |
| NVRO Nevro | Maintains: Equal-Weight | $5 → $4 | $5.73 | -30.19% | 4 | Dec 11, 2024 | |
| PRCT PROCEPT BioRobotics | Reinstates: Overweight | $112 | $62.25 | +79.92% | 7 | Dec 3, 2024 | |
| ITGR Integer Holdings | Reinstates: Overweight | $160 | $129.87 | +23.20% | 2 | Dec 3, 2024 | |
| IRTC iRhythm Technologies | Reinstates: Equal-Weight | $86 | $119.44 | -28.00% | 2 | Dec 3, 2024 |
LeMaitre Vascular
Feb 13, 2025
Initiates: Equal-Weight
Price Target: $95
Current: $99.54
Upside: -4.56%
Nevro
Dec 11, 2024
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $5.73
Upside: -30.19%
PROCEPT BioRobotics
Dec 3, 2024
Reinstates: Overweight
Price Target: $112
Current: $62.25
Upside: +79.92%
Integer Holdings
Dec 3, 2024
Reinstates: Overweight
Price Target: $160
Current: $129.87
Upside: +23.20%
iRhythm Technologies
Dec 3, 2024
Reinstates: Equal-Weight
Price Target: $86
Current: $119.44
Upside: -28.00%